Previous 10 | Next 10 |
Alkermes to Participate in the Jefferies London Healthcare Conference PR Newswire DUBLIN , Nov. 7, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies London Healthcare Conferen...
2023-11-06 08:40:13 ET More on Health Care Stocks Merck therapy shows improved survival in certain kidney cancer patients Pfizer: Ignore The Noise And Buy This Deep Value AstraZeneca to invest $245M in Cellectis to strengthen gene therapy portfolio Arexvy Put...
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement PR Newswire DUBLIN , Oct. 31 , 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the Registration Statement on Form 10, as amended (Form 10), filed by Mural ...
NORTHAMPTON, MA / ACCESSWIRE / October 31, 2023 / Alkermes Originally published in Alkermes September 2023 Corporate Responsibility Report Stakeholder Engagement We recognize that our stakeholders - including employees, healthcare providers, patients, caregivers, investors, policy makers,...
2023-10-25 16:28:08 ET Alkermes plc (ALKS) Q3 2023 Results Earnings Conference Call October 25, 2023, 08:00 AM ET Company Participants Sandra Coombs - Senior Vice President, Corporate Affairs and Investor Relations Iain Brown - Senior Vice President and Chief Financi...
2023-10-25 07:05:53 ET More on Alkermes Alkermes: A Complicated Story Right Now Lybalvi: Weighing In Light, But Tipping Alkermes' Scales Evercore ISI upgrades Alkermes to outperform, cites orexin potential Alkermes Q3 2023 Earnings Preview Seeking Alp...
St. Joe Company (The) (JOE) is expected to report for Q1 2024 Meta Platforms Inc. (META) is expected to report $3.62 for Q3 2023 Industrial Logistics Properties Trust (ILPT) is expected to report $0.11 for Q3 2023 Mid-America Apartment Communities Inc. (MAA) is expected to report $2.2...
Alkermes plc Reports Third Quarter 2023 Financial Results PR Newswire — Third Quarter Revenues of $380.9 Million; Net Sales of Proprietary Products Increased Approximately 16% Year-Over-Year — — GAAP Net Income of $47.8 Million and N...
Alkermes plc (ALKS) is expected to report $0.31 for Q3 2023
2023-10-24 14:15:19 ET More on Alkermes Alkermes: A Complicated Story Right Now Lybalvi: Weighing In Light, But Tipping Alkermes' Scales Alkermes plc 2023 Q2 - Results - Earnings Call Presentation Alkermes Q3 2023 Earnings Preview Alkermes to grant Te...
News, Short Squeeze, Breakout and More Instantly...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Alkermes plc Reports Second Quarter 2024 Financial Results PR Newswire — Second Quarter Revenues of $399.1 Million — — Net Sales of Proprietary Products Increased Approximately 16% Year-Over-Year — — GAAP Net Income from C...
2024-07-22 10:45:03 ET Enbridge Inc (ENB) ENB is trading UP for the last 5 days, and it at trading at $36.59 with volume of 731,965 and a one day change of $0.05 (0.14%). Enbridge Inc has a 52-week low of 31.03 and a 52-week high of $38.36. The business's 50-day moving average price...